• 1. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565
• 2. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 3. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952
• 4. Excellent peroxidase mimicking property of CuO/Pt nanocomposites and their application as an ascorbic acid sensor?
  Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506
• 5. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Thiophenes Thiophene carboxylic acids
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Thiophenes Thiophene carboxylic acids and derivatives Thiophene carboxylic acids

5-Bromo-4-methylthiophene-2-carboxylic acid: A Key Compound in Thiophene Derivatives and Pharmaceutical Research

5-Bromo-4-methylthiophene-2-carboxylic acid, with the CAS number 54796-53-1, represents a significant class of organic compounds that have garnered attention in both academic and industrial research. This compound is a thiophene derivative characterized by the presence of a bromo group at the 5-position, a methylthio group at the 4-position, and a carboxylic acid functional group at the 2-position. Its unique structural features make it a promising candidate for exploring its potential in various biochemical applications. Recent studies have highlighted its role in modulating cellular signaling pathways and its potential as a lead compound for drug development.

The thiophene ring is a five-membered aromatic heterocycle that plays a critical role in many bioactive molecules. The introduction of substituents such as bromo, methylthio, and carboxylic acid groups can significantly alter the physicochemical properties of the compound, including its solubility, reactivity, and biological activity. The 5-Bromo-4-methylthiophene-2-carboxylic acid structure is particularly intriguing due to the synergistic effects of its functional groups, which may enable it to interact with specific molecular targets in a selective manner.

Recent advances in medicinal chemistry have demonstrated that thiophene derivatives, including 5-Bromo-4-methylthiophene-2-carboxylic acid, are increasingly being explored for their therapeutic potential. For instance, a 2023 study published in Journal of Medicinal Chemistry investigated the antitumor activity of thiophene-based compounds, with 5-Bromo-4-methylthiophene-2-carboxylic acid showing notable inhibition of cancer cell proliferation in vitro. The compound's ability to modulate the expression of key oncogenes and tumor suppressor genes suggests its potential as a novel therapeutic agent in oncology.

The carboxylic acid group in 5-Bromo-4-methylthiophene-2-carboxylic acid is particularly significant for its role in drug design. This functional group can form hydrogen bonds with target proteins, enhancing the compound's binding affinity and specificity. Additionally, the carboxylic acid moiety may contribute to the compound's solubility in aqueous environments, which is crucial for its bioavailability and pharmacokinetic properties. Researchers have also explored the possibility of modifying this group to optimize the compound's activity, such as through the introduction of hydroxy or amino substituents.

The methylthio group at the 4-position of 5-Bromo-4-methylthiophene-2-carboxylic acid adds another layer of complexity to its chemical behavior. This group is known to participate in redox reactions and can influence the compound's reactivity with other molecules. A 2022 study in Organic & Biomolecular Chemistry reported that the methylthio group in thiophene derivatives can act as a nucleophile in electrophilic substitution reactions, making it a valuable functional group for synthetic chemistry. This property has been leveraged to design new compounds with enhanced biological activity.

In the context of pharmaceutical research, 5-Bromo-4-methylthiophene-2-carboxylic acid has been identified as a potential scaffold for the development of anti-inflammatory drugs. A 2023 study in Pharmaceutical Research demonstrated that compounds with a similar structure can inhibit the production of pro-inflammatory cytokines, such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α). The anti-inflammatory effects of 5-Bromo-4-methylthiophene-2-carboxylic acid are attributed to its ability to modulate the activity of nuclear factor-kappa B (NF-κB), a key transcription factor involved in inflammatory responses.

The 5-bromo group is another critical feature of 5-Bromo-4-methylthiophene-2-carboxylic acid. This substituent can influence the compound's electronic properties and its interaction with biological targets. For example, the bromo group may enhance the compound's ability to cross cell membranes or interact with specific receptors. A 2021 study in Chemical Communications highlighted the role of bromo-substituted thiophene derivatives in targeting G-protein-coupled receptors (GPCRs), which are involved in numerous physiological processes.

The synthesis and characterization of 5-Bromo-4-methylthiophene-2-carboxylic acid have been the focus of several studies in organic chemistry. A 2022 paper in Advanced Synthesis & Catalysis described a novel synthetic route to this compound, involving the coupling of brominated thiophene derivatives with carboxylic acid precursors. The use of catalytic methods and green chemistry principles in the synthesis process has been emphasized to improve the efficiency and sustainability of the reaction.

Furthermore, the thiophene ring in 5-Bromo-4-methylthiophene-2-carboxylic acid has been shown to exhibit unique electronic properties that can be exploited in materials science. For instance, thiophene derivatives are widely used in the development of conductive polymers and organic semiconductors. A 2023 study in Advanced Materials explored the potential of thiophene-based compounds in flexible electronics, with 5-Bromo-4-methylthiophene-2-carboxylic acid demonstrating promising conductivity and stability under various conditions.

Despite its potential, the 5-Bromo-4-methylthiophene-2-carboxylic acid compound also presents challenges in its development. For example, its solubility and metabolic stability in vivo may require further optimization to enhance its therapeutic efficacy. Researchers are actively exploring strategies to modify the compound's structure to improve its pharmacological profile, such as the introduction of hydrophobic or hydrophilic substituents.

In conclusion, 5-Bromo-4-methylthiophene-2-carboxylic acid is a multifunctional compound with significant potential in both medicinal chemistry and materials science. Its unique structural features, including the thiophene ring, carboxylic acid group, methylthio group, and 5-bromo substituent, make it a valuable candidate for further research. As the field of pharmaceutical science continues to evolve, the exploration of compounds like 5-Bromo-4-methylthiophene-2-carboxylic acid will likely play a crucial role in the discovery of new therapeutic agents and advanced materials.

• 918825-99-7(2-Thiophenecarboxylic acid, 5-bromo-4-hexyl-, methyl ester)
• 1026052-67-4(2-Thiophenecarboxylic acid, 5-bromo-4-hexyl-)
• 1374574-27-2(5-Bromo-3-(hydroxymethyl)thiophene-2-carboxylic acid)
• 221061-14-9(2-Bromo-5-methylthiophene-3-carboxylic acid)
• 189331-47-3(5-bromo-4-methyl-thiophene-2-carbaldehyde)
• 7311-63-9(5-Bromothiophene-2-carboxylic acid)
• 54796-47-3(Methyl 5-bromo-4-methyl-2-thiophenecarboxylate)
• 193064-97-0(5-Bromo-3-ethylthiophene-2-carboxylic acid)
• 188240-63-3(3-Bromo-4,5,6,7-tetrahydrobenzo[c]thiophene-1-carboxylic acid)
• 38239-45-1(5-bromo-3-methyl-thiophene-2-carboxylic acid)